Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3094893067;93068;93069 chr2:178548784;178548783;178548782chr2:179413511;179413510;179413509
N2AB2930788144;88145;88146 chr2:178548784;178548783;178548782chr2:179413511;179413510;179413509
N2A2838085363;85364;85365 chr2:178548784;178548783;178548782chr2:179413511;179413510;179413509
N2B2188365872;65873;65874 chr2:178548784;178548783;178548782chr2:179413511;179413510;179413509
Novex-12200866247;66248;66249 chr2:178548784;178548783;178548782chr2:179413511;179413510;179413509
Novex-22207566448;66449;66450 chr2:178548784;178548783;178548782chr2:179413511;179413510;179413509
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCC
  • RefSeq wild type template codon: CGG
  • Domain: Ig-150
  • Domain position: 22
  • Structural Position: 34
  • Q(SASA): 0.359
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/D None None 0.989 N 0.667 0.403 0.705984459088 gnomAD-4.0.0 2.05387E-06 None None None None I None 0 0 None 0 0 None 0 0 1.79894E-06 0 1.65673E-05
A/V None None 0.961 N 0.478 0.273 0.611151671824 gnomAD-4.0.0 6.84625E-07 None None None None I None 0 0 None 0 0 None 0 0 8.99471E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.5157 ambiguous 0.5112 ambiguous -0.377 Destabilizing 1.0 D 0.544 neutral None None None None I
A/D 0.6223 likely_pathogenic 0.5986 pathogenic -0.264 Destabilizing 0.989 D 0.667 neutral N 0.466853195 None None I
A/E 0.5336 ambiguous 0.5227 ambiguous -0.23 Destabilizing 0.991 D 0.613 neutral None None None None I
A/F 0.5484 ambiguous 0.5389 ambiguous -0.398 Destabilizing 0.999 D 0.72 prob.delet. None None None None I
A/G 0.1734 likely_benign 0.1579 benign -0.626 Destabilizing 0.961 D 0.473 neutral N 0.466546551 None None I
A/H 0.5976 likely_pathogenic 0.596 pathogenic -0.554 Destabilizing 1.0 D 0.704 prob.neutral None None None None I
A/I 0.4274 ambiguous 0.3976 ambiguous 0.228 Stabilizing 0.991 D 0.661 neutral None None None None I
A/K 0.6038 likely_pathogenic 0.6068 pathogenic -0.457 Destabilizing 0.991 D 0.613 neutral None None None None I
A/L 0.2895 likely_benign 0.2828 benign 0.228 Stabilizing 0.97 D 0.573 neutral None None None None I
A/M 0.3752 ambiguous 0.3559 ambiguous -0.032 Destabilizing 1.0 D 0.641 neutral None None None None I
A/N 0.3833 ambiguous 0.3733 ambiguous -0.435 Destabilizing 0.991 D 0.703 prob.neutral None None None None I
A/P 0.3013 likely_benign 0.2125 benign 0.073 Stabilizing 0.151 N 0.337 neutral N 0.377927488 None None I
A/Q 0.4622 ambiguous 0.458 ambiguous -0.439 Destabilizing 0.996 D 0.67 neutral None None None None I
A/R 0.4897 ambiguous 0.4966 ambiguous -0.307 Destabilizing 0.996 D 0.66 neutral None None None None I
A/S 0.1087 likely_benign 0.1087 benign -0.825 Destabilizing 0.489 N 0.348 neutral N 0.451595741 None None I
A/T 0.1236 likely_benign 0.1188 benign -0.675 Destabilizing 0.433 N 0.319 neutral N 0.43289255 None None I
A/V 0.2363 likely_benign 0.2197 benign 0.073 Stabilizing 0.961 D 0.478 neutral N 0.46933614 None None I
A/W 0.8674 likely_pathogenic 0.8595 pathogenic -0.807 Destabilizing 1.0 D 0.714 prob.delet. None None None None I
A/Y 0.6173 likely_pathogenic 0.6066 pathogenic -0.293 Destabilizing 0.999 D 0.718 prob.delet. None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.